Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Infantile Spasms Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Infantile Spasms Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Infantile Spasms Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Insys Therapeutics
Mallinckrodt
GW Pharmaceuticals
Anavex Life Sciences
H Lundbeck
Catalyst Pharmaceuticals
Retrophin
Orphelia Pharma
Valerion Therapeutics
By Type:
Oral
Injection
By End-User:
Hospital
Clinic
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Infantile Spasms Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Infantile Spasms Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 China Infantile Spasms Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Infantile Spasms Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Infantile Spasms Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Injection
4 Segmentation of Infantile Spasms Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Infantile Spasms Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Infantile Spasms Therapeutics in Hospital
-
4.4.2 Market Size and Growth Rate of Infantile Spasms Therapeutics in Clinic
5 Market Analysis by Regions
-
5.1 China Infantile Spasms Therapeutics Production Analysis by Regions
-
5.2 China Infantile Spasms Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Infantile Spasms Therapeutics Landscape Analysis
-
6.1 North China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
6.2 North China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
7 Central China Infantile Spasms Therapeutics Landscape Analysis
-
7.1 Central China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
8 South China Infantile Spasms Therapeutics Landscape Analysis
-
8.1 South China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
8.2 South China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
9 East China Infantile Spasms Therapeutics Landscape Analysis
-
9.1 East China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
9.2 East China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Infantile Spasms Therapeutics Landscape Analysis
-
10.1 Northeast China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Infantile Spasms Therapeutics Landscape Analysis
-
11.1 Southwest China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Infantile Spasms Therapeutics Landscape Analysis
-
12.1 Northwest China Infantile Spasms Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Infantile Spasms Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Insys Therapeutics
-
13.1.1 Insys Therapeutics Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Mallinckrodt
-
13.2.1 Mallinckrodt Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 GW Pharmaceuticals
-
13.3.1 GW Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Anavex Life Sciences
-
13.4.1 Anavex Life Sciences Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 H Lundbeck
-
13.5.1 H Lundbeck Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Catalyst Pharmaceuticals
-
13.6.1 Catalyst Pharmaceuticals Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Retrophin
-
13.7.1 Retrophin Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Orphelia Pharma
-
13.8.1 Orphelia Pharma Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Valerion Therapeutics
-
13.9.1 Valerion Therapeutics Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Infantile Spasms Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Infantile Spasms Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Infantile Spasms Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Infantile Spasms Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Infantile Spasms Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Infantile Spasms Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Table China Infantile Spasms Therapeutics Production by Regions
-
Table China Infantile Spasms Therapeutics Production Share by Regions
-
Figure China Infantile Spasms Therapeutics Production Share by Regions in 2016
-
Figure China Infantile Spasms Therapeutics Production Share by Regions in 2021
-
Figure China Infantile Spasms Therapeutics Production Share by Regions in 2027
-
Table China Infantile Spasms Therapeutics Consumption by Regions
-
Table China Infantile Spasms Therapeutics Consumption Share by Regions
-
Figure China Infantile Spasms Therapeutics Consumption Share by Regions in 2016
-
Figure China Infantile Spasms Therapeutics Consumption Share by Regions in 2021
-
Figure China Infantile Spasms Therapeutics Consumption Share by Regions in 2027
-
Table North China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure North China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure North China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table North China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Central China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table South China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure South China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure South China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table South China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table East China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure East China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure East China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table East China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Infantile Spasms Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Infantile Spasms Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Infantile Spasms Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Infantile Spasms Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Infantile Spasms Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Insys Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insys Therapeutics
-
Figure Sales and Growth Rate Analysis of Insys Therapeutics
-
Figure Revenue and Market Share Analysis of Insys Therapeutics
-
Table Product and Service Introduction of Insys Therapeutics
-
Table Company Profile and Development Status of Mallinckrodt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt
-
Figure Sales and Growth Rate Analysis of Mallinckrodt
-
Figure Revenue and Market Share Analysis of Mallinckrodt
-
Table Product and Service Introduction of Mallinckrodt
-
Table Company Profile and Development Status of GW Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of GW Pharmaceuticals
-
Figure Revenue and Market Share Analysis of GW Pharmaceuticals
-
Table Product and Service Introduction of GW Pharmaceuticals
-
Table Company Profile and Development Status of Anavex Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anavex Life Sciences
-
Figure Sales and Growth Rate Analysis of Anavex Life Sciences
-
Figure Revenue and Market Share Analysis of Anavex Life Sciences
-
Table Product and Service Introduction of Anavex Life Sciences
-
Table Company Profile and Development Status of H Lundbeck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck
-
Figure Sales and Growth Rate Analysis of H Lundbeck
-
Figure Revenue and Market Share Analysis of H Lundbeck
-
Table Product and Service Introduction of H Lundbeck
-
Table Company Profile and Development Status of Catalyst Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Catalyst Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Catalyst Pharmaceuticals
-
Table Product and Service Introduction of Catalyst Pharmaceuticals
-
Table Company Profile and Development Status of Retrophin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Retrophin
-
Figure Sales and Growth Rate Analysis of Retrophin
-
Figure Revenue and Market Share Analysis of Retrophin
-
Table Product and Service Introduction of Retrophin
-
Table Company Profile and Development Status of Orphelia Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphelia Pharma
-
Figure Sales and Growth Rate Analysis of Orphelia Pharma
-
Figure Revenue and Market Share Analysis of Orphelia Pharma
-
Table Product and Service Introduction of Orphelia Pharma
-
Table Company Profile and Development Status of Valerion Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valerion Therapeutics
-
Figure Sales and Growth Rate Analysis of Valerion Therapeutics
-
Figure Revenue and Market Share Analysis of Valerion Therapeutics
-
Table Product and Service Introduction of Valerion Therapeutics
-
